NYSE - Delayed Quote USD
Edwards Lifesciences Corporation (EW)
77.52
-0.25
(-0.32%)
At close: June 6 at 4:00:02 PM EDT
77.51
-0.01
(-0.01%)
After hours: June 6 at 7:29:46 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 26 | 25 | 31 | 30 |
| Avg. Estimate | 0.62 | 0.6 | 2.47 | 2.75 |
| Low Estimate | 0.6 | 0.56 | 2.41 | 2.61 |
| High Estimate | 0.65 | 0.65 | 2.55 | 2.93 |
| Year Ago EPS | 0.7 | 0.67 | 2.43 | 2.47 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 26 | 25 | 32 | 31 |
| Avg. Estimate | 1.49B | 1.47B | 5.89B | 6.45B |
| Low Estimate | 1.45B | 1.44B | 5.77B | 6.28B |
| High Estimate | 1.51B | 1.5B | 5.98B | 6.66B |
| Year Ago Sales | 1.63B | 1.35B | 5.44B | 5.89B |
| Sales Growth (year/est) | -9.01% | 8.90% | 8.30% | 9.51% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.69 | 0.59 | 0.55 | 0.6 |
| EPS Actual | 0.7 | 0.67 | 0.59 | 0.64 |
| Difference | 0.01 | 0.08 | 0.04 | 0.04 |
| Surprise % | 0.88% | 13.97% | 6.39% | 7.46% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.62 | 0.6 | 2.47 | 2.75 |
| 7 Days Ago | 0.62 | 0.6 | 2.47 | 2.75 |
| 30 Days Ago | 0.62 | 0.6 | 2.47 | 2.75 |
| 60 Days Ago | 0.61 | 0.61 | 2.45 | 2.75 |
| 90 Days Ago | 0.62 | 0.61 | 2.45 | 2.75 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 14 | 1 | 17 | 1 |
| Up Last 30 Days | 14 | 1 | 19 | 1 |
| Down Last 7 Days | 4 | -- | 5 | -- |
| Down Last 30 Days | 5 | -- | 4 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EW | -11.19% | -10.94% | 1.53% | 11.36% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 5/22/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/13/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 4/25/2025 |
| Maintains | Baird: Neutral to Neutral | 4/24/2025 |
| Upgrade | Piper Sandler: Neutral to Overweight | 4/24/2025 |
| Maintains | Truist Securities: Hold to Hold | 4/11/2025 |
Related Tickers
BSX Boston Scientific Corporation
102.09
-0.72%
SYK Stryker Corporation
383.89
+0.21%
MDT Medtronic plc
87.44
+0.51%
ABT Abbott Laboratories
133.58
-0.27%
DXCM DexCom, Inc.
86.67
+1.08%
PEN Penumbra, Inc.
258.90
+0.20%
MASI Masimo Corporation
171.97
+4.40%
ZBH Zimmer Biomet Holdings, Inc.
92.38
+0.50%
STE STERIS plc
243.72
+0.06%
PODD Insulet Corporation
311.77
-1.70%